Advertisement
Research Article| Volume 2, ISSUE 3, P193-199, July 2013

Download started.

Ok

Validation of MRI predictors of multiple sclerosis diagnosis in children with acute CNS demyelination

  • Author Footnotes
    1 These authors contributed equally to the present work.
    L.H. Verhey
    Footnotes
    1 These authors contributed equally to the present work.
    Affiliations
    Program in Neuroscience & Mental Health, The Hospital for Sick Children, Toronto, Canada

    Institute of Medical Science, University of Toronto, Toronto, Canada
    Search for articles by this author
  • Author Footnotes
    1 These authors contributed equally to the present work.
    E.D. van Pelt-Gravesteijn
    Footnotes
    1 These authors contributed equally to the present work.
    Affiliations
    Department of Neurology, Erasmus MC, Rotterdam, The Netherlands
    Search for articles by this author
  • I.A. Ketelslegers
    Affiliations
    Department of Neurology, Erasmus MC, Rotterdam, The Netherlands
    Search for articles by this author
  • R.F. Neuteboom
    Affiliations
    Department of Pediatric Neurology, Erasmus MC, Sophia Children's Hospital, Rotterdam, The Netherlands
    Search for articles by this author
  • C.E. Catsman-Berrevoets
    Affiliations
    Department of Pediatric Neurology, Erasmus MC, Sophia Children's Hospital, Rotterdam, The Netherlands
    Search for articles by this author
  • B.M. Feldman
    Affiliations
    Division of Rheumatology, Department of Pediatrics, The Hospital for Sick Children, Toronto, Canada

    Institute of Health Policy, Management & Evaluation, University of Toronto, Toronto, Canada

    Department of Medicine, University of Toronto, Toronto, Canada

    Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
    Search for articles by this author
  • D.L. Streiner
    Affiliations
    Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada

    Department of Psychiatry & Behavioural Neurosciences, McMaster University, Hamilton, Canada

    Department of Psychiatry, University of Toronto, Toronto, Canada
    Search for articles by this author
  • J.G. Sled
    Affiliations
    Department of Medical Biophysics, University of Toronto, Toronto, Canada

    Program in Physiology & Experimental Medicine, The Hospital for Sick Children, Toronto, Canada
    Search for articles by this author
  • R.Q. Hintzen
    Affiliations
    Department of Neurology, Erasmus MC, Rotterdam, The Netherlands

    Department of Pediatric Neurology, Erasmus MC, Sophia Children's Hospital, Rotterdam, The Netherlands
    Search for articles by this author
  • B Banwell
    Correspondence
    Corresponding author at: Division of Neurology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania, Rm 10018, Colket Research Building, 3501 Civic Center Boulevard, Philadelphia, PA 19104, United States. Tel.: +1 215 590 1710; fax: +1 215 590 2950.
    Affiliations
    Program in Neuroscience & Mental Health, The Hospital for Sick Children, Toronto, Canada

    Institute of Medical Science, University of Toronto, Toronto, Canada

    Division of Neurology, Department of Pediatrics, The Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, USA
    Search for articles by this author
  • Author Footnotes
    1 These authors contributed equally to the present work.
Published:February 04, 2013DOI:https://doi.org/10.1016/j.msard.2012.12.003

      Abstract

      Background

      In a recent Canadian prospective study of children with acute demyelinating syndromes (ADS), we demonstrated that the presence of T2 periventricular and T1-hypointense lesions predicted MS diagnosis. We aimed to validate these predictors in a Dutch cohort of children with ADS.

      Methods

      Participants with ADS were identified from a prospective cohort or archived dataset. MS was diagnosed based on clinical or MRI evidence of relapsing disease. Baseline MRI scans were evaluated for the presence of the two predictive parameters. Sensitivity, specificity, positive (LR+) and negative likelihood ratios (LR−), and positive (PPV) and negative predictive value (NPV) were calculated to evaluate the performance of the MRI parameters at classifying children as having MS or monophasic demyelination.

      Findings

      Of 115 children identified with ADS between December 1993 and December 2009, MRI scans from 87 children (45 prospective; 47 archived) were evaluated; scans of 28 children were excluded due to incomplete or poor quality imaging. Mean duration of observation was longer in the archived group (7.1 years, SD 3.5) than the prospective cohort (3.3 years, SD 1.4). 30 children were diagnosed with MS. Performance of the parameters was not statistically different between the prospective cohort (sensitivity 93.3% [68.1–99.8]; specificity 86.7% [69.3–96.2]; LR+ 7.0 [2.8–17.6]; LR− 0.08 [0.01–0.5]; PPV 77.8% [52.4–93.6]; NPV 96.3% [81.0–99.9]) and archived group (sensitivity 66.7% [38.4–88.2]; specificity 85.2% [66.3–95.8]; LR+ 4.5 [1.7–11.9]; LR− 0.4 [0.2–0.8]; PPV 71.4% [41.9–91.6]; NPV 82.1% [63.1–93.9]).

      Interpretation

      In an independent Dutch cohort, we confirm that the presence of ≥1 T2 periventricular and ≥1 T1-hypointense lesions reliably identifies children with MS.

      Funding

      Dutch MS Research Foundation.

      Highlights

      • We validate MRI parameters for predicting MS diagnosis in children.
      • T2 periventricular and T1-hypointense lesions are associated with MS diagnosis.
      • Prompt diagnosis of children with MS aids in counseling and management.
      • The MRI parameters may identify participants for clinical trials.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Multiple Sclerosis and Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Anlar B.
        • Basaran C.
        • Kose G.
        • Guven A.
        • Haspolat S.
        • Yakut A.
        • et al.
        Acute disseminated encephalomyelitis in children: outcome and prognosis.
        Neuropediatrics. 2003; 34: 194-199
        • Banwell B.
        • Bar-Or A.
        • Arnold D.L.
        • Sadovnick D.
        • Narayanan S.
        • McGowan M.
        • et al.
        Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.
        Lancet Neurology. 2011; 10: 436-445
        • Barkhof F.
        • Scheltens P.
        • Frequin S.T.
        • Nauta J.J.
        • Tas M.W.
        • Valk J.
        • et al.
        Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity.
        AJR American Journal of Roentgenology. 1992; 159: 1041-1047
        • Fletcher R.H.
        • Fletcher S.W.
        Diagnosis.
        in: Fletcher R.H. Fletcher S.W. Clinical Epidemiology: The Essentials. Lippincott Williams & Wilkins, Philadelphia2005: 35-58
        • Krupp L.B.
        • Banwell B.
        • Tenembaum S.
        Consensus definitions proposed for pediatric multiple sclerosis and related disorders.
        Neurology. 2007; 68: S7-12
        • Mikaeloff Y.
        • Adamsbaum C.
        • Husson B.
        • Vallee L.
        • Ponsot G.
        • Confavreux C.
        • et al.
        MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood.
        Brain. 2004; 127: 1942-1947
        • Neuteboom R.F.
        • Boon M.
        • Catsman Berrevoets C.E.
        • Vles J.S.
        • Gooskens R.H.
        • Stroink H.
        • et al.
        Prognostic factors after a first attack of inflammatory CNS demyelination in children.
        Neurology. 2008; 71: 967-973
        • Polman C.H.
        • Reingold S.C.
        • Edan G.
        • Filippi M.
        • Hartung H.P.
        • Kappos L.
        • et al.
        Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”.
        Annals of Neurology. 2005; 58: 840-846
        • Poser C.M.
        • Paty D.W.
        • Scheinberg L.
        • McDonald W.I.
        • Davis F.A.
        • Ebers G.C.
        • et al.
        New diagnostic criteria for multiple sclerosis: guidelines for research protocols.
        Annals of Neurology. 1983; 13: 227-231
        • Simon J.H.
        • Li D.
        • Traboulsee A.
        • Coyle P.K.
        • Arnold D.L.
        • Barkhof F.
        • et al.
        Standardized MR imaging protocol for multiple sclerosis: consortium of MS Centers consensus guidelines.
        AJNR American Journal of Neuroradiology. 2006; 27: 455-461
        • Sormani M.P.
        • Stubinski B.
        • Cornelisse P.
        • Rocak S.
        • Li D.
        • De S.N.
        Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis.
        Multiple Sclerosis (Houndmills, Basingstoke, England). 2011; 17: 541-549
        • Tenembaum S.
        • Chamoles N.
        • Fejerman N.
        Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients.
        Neurology. 2002; 59: 1224-1231
        • Tenembaum S.
        • Chitnis T.
        • Ness J.
        • Hahn J.S.
        Acute disseminated encephalomyelitis.
        Neurology. 2007; 68: S23-S36
        • Verhey L.H.
        • Branson H.M.
        • Shroff M.M.
        • Callen D.J.
        • Sled J.G.
        • Narayanan S.
        • et al.
        MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study.
        Lancet Neurology. 2011; 10: 1065-1073
        • Wingerchuk D.M.
        • Lennon V.A.
        • Pittock S.J.
        • Lucchinetti C.F.
        • Weinshenker B.G.
        Revised diagnostic criteria for neuromyelitis optica.
        Neurology. 2006; 66: 1485-1489